EU ORPHAN DRUGS PROMOTION IS SUCCESS CLAIMS BRUSSELS
August 1st, 2006
BY KEITH NUTHALL
THE EUROPEAN Commission has hailed a success its five-year-old system promoting the development of orphan drugs, noting 22 medicines for rare diseases have now received European Union marketing authorisation. Furthermore, 270 further potential treatments have been designated as orphan medicinal products undergoing clinical tests. "The results show that we are on the right track," said Brussels.
ENDS
THE EUROPEAN Commission has hailed a success its five-year-old system promoting the development of orphan drugs, noting 22 medicines for rare diseases have now received European Union marketing authorisation. Furthermore, 270 further potential treatments have been designated as orphan medicinal products undergoing clinical tests. "The results show that we are on the right track," said Brussels.
ENDS
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.